Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 09/30/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 56.77% | -111.82% | -96.26% | -96.26% | -119.46% |
| Total Depreciation and Amortization | 12.33% | 0.41% | -21.61% | -21.61% | 68.46% |
| Total Amortization of Deferred Charges | -77.45% | -52.62% | 45.44% | 45.44% | 100.75% |
| Total Other Non-Cash Items | -73.16% | 102.85% | 93.56% | 93.56% | 103.57% |
| Change in Net Operating Assets | -98.83% | 237.96% | 61.92% | 61.92% | 214.45% |
| Cash from Operations | 34.41% | 64.06% | 59.97% | 59.97% | 43.44% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.67% | 350.00% | 152.50% | 152.50% | 91.39% |
| Cash from Investing | 6.67% | 116.13% | 150.00% | 150.00% | 92.62% |
| Total Debt Issued | -32.55% | -42.95% | -50.52% | -50.52% | -47.70% |
| Total Debt Repaid | 28.20% | -0.42% | -888.16% | -888.16% | -23.56% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -34.17% | -64.96% | -78.84% | -78.84% | -56.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -82.46% | -82.46% | -92.81% |